Cargando…

The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer

Currently, alcoholic liver disease (ALD) is one of the most prevalent chronic liver diseases worldwide, representing one of the main etiologies of cirrhosis and hepatocellular carcinoma (HCC). Although we do not know the exact mechanisms by which only a selected group of patients with ALD progress t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Méndez-Sánchez, Nahum, Valencia-Rodriguez, Alejandro, Vera-Barajas, Alfonso, Abenavoli, Ludovico, Scarpellini, Emidio, Ponciano-Rodriguez, Guadalupe, Wang, David Q.-H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313221/ https://www.ncbi.nlm.nih.gov/pubmed/32582865 http://dx.doi.org/10.20517/2394-5079.2019.29

Ejemplares similares

The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2020)

Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

Gut Microbiota and Liver Transplantation: Immune Mechanisms behind the Rejection
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Liver Damage and COVID-19: At Least a “Two-Hit” Story in Systematic Review
por: Montori, Michele, et al.
Publicado: (2023)

Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease
por: Dallio, Marcello, et al.
Publicado: (2019)

Nutritional Support in Acute Liver Failure
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

Human Genes Involved in the Interaction between Host and Gut Microbiome: Regulation and Pathogenic Mechanisms
por: Boccuto, Luigi, et al.
Publicado: (2023)

Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic
por: Scarpellini, Emidio, et al.
Publicado: (2020)

Silymarin: An option to treat non-alcoholic fatty liver disease
por: Colica, Carmela, et al.
Publicado: (2017)

Body Composition and Non-alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2016)

Microbiome dysbiosis and alcoholic liver disease(☆)
por: Li, Fengyuan, et al.
Publicado: (2019)

Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2020)

From intestinal dysbiosis to alcohol-associated liver disease
por: Mendes, Beatriz Garcia, et al.
Publicado: (2020)

Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD)
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2021)

Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2021)

Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way
por: Abenavoli, Ludovico, et al.
Publicado: (2019)

Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
por: Mouzaki, Marialena, et al.
Publicado: (2016)

Gut dysbiosis as a driver in alcohol-induced liver injury
por: Fairfield, Bradley, et al.
Publicado: (2020)

From Pre- and Probiotics to Post-Biotics: A Narrative Review †
por: Scarpellini, Emidio, et al.
Publicado: (2021)

Mediterranean Diet: The Beneficial Effects of Lycopene in Non-Alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study
por: Abenavoli, Ludovico, et al.
Publicado: (2017)

Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation
por: Tkach, Sergii, et al.
Publicado: (2022)

Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota
por: Mori, Hideki, et al.
Publicado: (2022)

Impact of Immuno-Nutrition on the Nutritional Status, Inflammatory Response and Clinical Outcome of Clinic-Admitted Mild-Intensity-COVID-19 Patients: A Pilot, Perspective-Concluding Study
por: Basilico, Martina, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease severity, central fat mass and adinopectin: a close relationship
por: ABENAVOLI, LUDOVICO, et al.
Publicado: (2015)

Editorial: The Metabolic (Dysfunction) Associated Fatty Liver Disease (MAFLD)-Non-Alcoholic Fatty Liver Disease (NAFLD) Debate: A Forced Consensus and The Risk of a World Divide
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2022)

Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease
por: Saltzman, Emma T., et al.
Publicado: (2018)

Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist’s Perspective
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2020)

Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease
por: Gelli, Chiara, et al.
Publicado: (2017)

Decompressive Craniectomy in Severe Traumatic Brain Injury: The Intensivist’s Point of View
por: Vitali, Matteo, et al.
Publicado: (2023)

Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Oxidation of fish oil exacerbates alcoholic liver disease by enhancing intestinal dysbiosis in mice
por: Feng, Ruibing, et al.
Publicado: (2020)

Artificial sweeteners are related to non-alcoholic fatty liver disease: Microbiota dysbiosis as a novel potential mechanism
por: Emamat, Hadi, et al.
Publicado: (2020)

Distinctive gut microbial dysbiosis between chronic alcoholic fatty liver disease and metabolic-associated fatty liver disease in mice
por: Kang, Kai, et al.
Publicado: (2021)

Dysbiosis of gut microbiota after cholecystectomy is associated with non‐alcoholic fatty liver disease in mice
por: Wang, Qihan, et al.
Publicado: (2021)

Alcohol-dependent downregulation of apolipoprotein H exacerbates fatty liver and gut microbiota dysbiosis in mice
por: Liu, Yaming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9ogcqo9ssp0iae0beipsv95fhe